May 2018

Features

Handling the Unhappy Premium IOL Patient

An ounce of prevention is worth a pound of cure, says this surgeon.

No Capsular Support: Do ACIOLs Still Make Sense?

New alternatives have many surgeons shying away from ACIOLs —but there’s still a place for them.

Is a Private Equity Deal Right for You? (Pt 2)

Surgeons and business experts answer ophthalmologists’ main questions. (Part two of two.)

PCO: What’s Wrong With Doing a YAG?

A lot of effort is being devoted to avoiding PCO, but some surgeons say a YAG isn’t that bad.

Planning for the Best Outcomes

Do more than just hope for them with intelligent cataract surgery planning for post-refractive eyes.

Departments

Review News

AMD Patients Recover Vision After Stem Cell Treatment

Ophthalmic Product Development Insights

Drug Repurposing: A Case Study of Accelerated Development

Technology Update

New High-Tech IOL Options in the Pipeline

Three revolutionary ideas may help to raise the bar for post-surgery refractive outcomes and patient satisfaction.

Retinal Insider

Digging Deeper Into Protocol U

The DRCR Network’s study of two treatments for diabetic macular edema revealed the pros and cons of the approaches.

Refractive/Cataract Rundown

Is LVC Possible In CVD Patients?

Long considered an absolute contraindication, collagen vascular disease may not always be a bar for carefully selected patients.

Glaucoma Management

Diagnosing Early Glaucoma: Pearls and Pitfalls

In our ongoing attempts to detect the disease at its earliest stages, new technologies are showing promise.

Product News

Bausch + Lomb’s New Vitrectomy Cutters

Research Review

Outcomes of Laser Peripheral Iridotomy

Wills Eye Resident Case Series

May 2018 Wills Eye Resident Case Series

A middle-aged man with esophageal cancer presents with a presumed case of central serous chorioretinopathy.

Current Issue